Concerns for the use of continuous cell lines and certain promoters for producing vaccine antigens by recombinant technology.
Hilleman
M R
MR
Merck Sharp & Dohme Research Laboratories, West Point, PA 19486.
Gerety
R J
RJ
Ellis
R W
RW
D000941:Antigens / Q000235:genetics*; D002460:Cell Line; D003001:Cloning, Molecular; D046508:Culture Techniques / Q000379:methods; D006801:Humans; D011401:Promoter Regions, Genetic; D011994:Recombinant Proteins; D014612:Vaccines
D000941:Antigens; D011994:Recombinant Proteins; D014612:Vaccines